Myelodysplastic syndromes

The VA rates Myelodysplastic syndromes under Diagnostic Code 7725 at 30%, 60%, 100%. The minimum 30% rating requires: Requiring at least 1 but no more than 3 blood or platelet transfusions per 12-month period; infections requiring hospitalization at least 1 but no more than 2 times per 12-month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent (ESA) for 12 weeks or less per 12-month period. The maximum 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy.

The VA rates Myelodysplastic syndromes under Diagnostic Code (DC) 7725, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

A 30% rating requires: Requiring at least 1 but no more than 3 blood or platelet transfusions per 12-month period; infections requiring hospitalization at least 1 but no more than 2 times per 12-month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent (ESA) for 12 weeks or less per 12-month period. A 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.

Yes — a 100% rating for Myelodysplastic syndromes alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.

The key evidence for Myelodysplastic syndromes is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.

The C&P examiner uses a Hematologic & Lymphatic System DBQ and evaluates your condition against the DC 7725 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.